INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

An expert overview of the literature, useful as background reading.

357 studies · page 14 of 15

2007 / Consensus conference and literature review

An expert consensus recommends pregnant and lactating women consume at least 200 mg DHA daily, including one to two portions of sea fish per week.

The PERILIP project, with the Early Nutrition Programming Project, performed literature reviews and held a consensus conference to develop recommendations on dietary fat intake during pregnancy and lactation. The panel concluded that total fat intake should align with general population guidelines and recommended an average intake of at least 200 mg DHA/d. Women of childbearing age should aim for one to two portions of sea fish weekly, including oily fish, noting that preformed DHA is far more effective for fetal brain deposition than alpha-linolenic acid. Intakes up to 1 g/d DHA or 2.7 g/d n-3 long-chain PUFA were noted as used in trials without significant adverse effects, and long-chain n-3 fatty acid intake resulted in slightly longer pregnancy duration.

NANO counterpoint →

Koletzko B, Cetin I, Brenna JT, et al. Br J Nutr, 2007. PMID 17688705

2007 / Narrative review

Curcumin is safe up to 12 g/day in humans but exhibits poor bioavailability due to poor absorption, rapid metabolism, and rapid systemic elimination.

This review examines the bioavailability and pharmacologic properties of curcumin, a polyphenol derived from turmeric. Phase I clinical trials demonstrate that curcumin is safe even at high doses up to 12 g/day in humans, but it has poor bioavailability driven by poor absorption, rapid metabolism, and rapid systemic elimination. Approaches to enhance bioavailability include adjuvants like piperine, liposomal curcumin, nanoparticles, phospholipid complexes, and structural analogues such as EF-24. Despite low bioavailability, therapeutic efficacy has been documented against human diseases including cancer, cardiovascular diseases, diabetes, arthritis, neurological diseases, and Crohn's disease.

Anand P, Kunnumakkara AB, Newman RA, et al. Mol Pharm, 2007. PMID 17999464

2007 / Narrative review

Seychelles data through age 9 showed no consistent adverse link between prenatal methyl mercury from fish and child neurodevelopment.

This review examines nutrients in fish essential for brain growth alongside risks of methyl mercury (MeHg) exposure, focusing on the Seychelles Child Development Study where fish is consumed daily. In the Seychelles cohort, evaluations of children through 9 years of age revealed no consistent pattern of adverse associations with prenatal MeHg exposure. Recent research has evaluated nutrients like long-chain polyunsaturated fatty acids, iodine, iron, and choline. Preliminary findings suggest that beneficial nutrients from fish might counter adverse effects of MeHg on the developing nervous system.

Shows an association, not proof of cause and effect.

Myers GJ, Davidson PW, Strain JJ J Nutr, 2007. PMID 18029503

2007 / Narrative review

Extended-duration work shifts are linked to increased fatigue and impaired performance and safety among nurses and physicians-in-training.

A review examined evidence on health care provider work hours, sleep deprivation, safety, and performance. Nurses working shifts greater than 12.5 hours are at significantly increased risk of decreased vigilance, occupational injury, or making a medical error. Physicians-in-training working traditional > 24-hour on-call shifts face increased risks of occupational sharps injuries, motor vehicle crashes, and serious or fatal medical errors. Compared to 16-hour shifts, on-call residents working overnight have twice as many attentional failures, commit 36% more serious medical errors, and report 300% more fatigue-related medical errors leading to a patient's death.

Shows an association, not proof of cause and effect.

Lockley SW, Barger LK, Ayas NT, et al. Jt Comm J Qual Patient Saf, 2007. PMID 18173162

2006 / Narrative review

Inhibition of MAO by tobacco constituents enhances addiction from smoking, and MAO reduction in alcoholics likely stems from concurrent tobacco use.

This review examines PET-scan and neurochemical data on monoamine oxidase (MAO) inhibition related to tobacco and alcohol use. PET-scan studies indicate that brain MAO activity decreases in tobacco smokers and reverts to control levels upon quitting, likely due to MAO-inhibiting tobacco constituents. A similar reversible decrease in MAO activity reported in Type II alcoholism is probably attributable to concurrent tobacco use. The authors conclude that MAO inhibition by tobacco and smoke constituents enhances tobacco addiction.

van Amsterdam J, Talhout R, Vleeming W, et al. Life Sci, 2006. PMID 16884739

2006 / Clinical recommendations / narrative review

The American Thyroid Association recommends 150 µg daily iodine supplementation for women during pregnancy and lactation.

Maternal dietary iodine is essential for thyroxine production and normal fetal brain development, with insufficiency potentially causing irreversible fetal brain damage. In 2001-2002, US median urinary iodine was 168 µg/L, and pregnant women had a median of 173 µg/L (95% CI 75-229 µg/L), though the lower 95% CI fell below the WHO-recommended 150 µg/L threshold. Consequently, the American Thyroid Association recommends women take a 150 µg iodine supplement daily during pregnancy and lactation and that all prenatal vitamins contain 150 µg of iodine.

Public Health Committee of the American Thyroid Association, Becker DV, Braverman LE, et al. Thyroid, 2006. PMID 17042677

2005 / Historical article and interviews

A historical review details the Minnesota Starvation Experiment, where semistarvation led to >25% weight loss, anemia, fatigue, and neurological deficits.

During World War II, Ancel Keys and colleagues subjected 36 conscientious objectors to a grueling semistarvation study to evaluate the physical and psychologic effects of starvation and refeeding. Most participants lost >25% of their weight, and many experienced anemia, fatigue, apathy, extreme weakness, irritability, neurological deficits, and lower extremity edema. In 2003-2004, 18 surviving participants were interviewed; all expressed strong convictions about nonviolence, and the men were unanimous in stating they would participate again despite their suffering.

Kalm LM, Semba RD J Nutr, 2005. PMID 15930436

2005 / Narrative review

Controlled studies showing that chelation therapy improves outcomes for putative mercury poisoning are lacking.

Public awareness of mercury's potential health problems has grown, but there is also an increasing tendency to attribute unexplained neurological and other symptoms to mercury without confirmed significant exposure. Diagnosing mercury intoxication remains challenging because signs overlap with other causes such as undiagnosed neurological disorders, medication effects, vitamin or mineral deficiencies, or stress. Controlled studies demonstrating that chelation therapy improves patient outcomes are lacking, and physicians should communicate the risks of chelating drugs before treatment.

Risher JF, Amler SN Neurotoxicology, 2005. PMID 16009427

2005 / Narrative review

Dietary galactose restriction reverses acute neonatal dysfunction in galactosemia, but chronic and progressive neurological impairments can still occur.

This review summarizes current knowledge on the neurological complications and pathophysiology of classical galactosemia. While initiating dietary restriction of galactose in the newborn period reverses hepatic, renal, brain, and immune dysfunction and reduces accumulated metabolites, patients often experience substantial motor, cognitive, and psychiatric impairments despite dietary treatment. Chronic and progressive neurological complications can develop even in patients who were spared neonatal symptoms.

Ridel KR, Leslie ND, Gilbert DL Pediatr Neurol, 2005. PMID 16087312

2005 / Narrative review

Ephedra was banned by the FDA in 2004 after causing stroke, arrhythmia, and death, while replacement supplements largely lack efficacy and safety data.

This review examines the regulatory framework of the Dietary Supplement Health and Education Act of 1994 (DSHEA) and the history of ephedra, a supplement used for weight loss. Due to sympathomimetic activity, ephedra caused stroke, cardiac arrhythmia, and death, prompting an FDA ban on its sale effective April 12, 2004. An evaluation of other dietary supplements attempting to fill the void demonstrates a general lack of safety and efficacy data. Ten years after DSHEA, the industry remains controversial and a concern for consumer safety.

Seamon MJ, Clauson KA J Herb Pharmacother, 2005. PMID 16520299

2004 / Narrative review and case reports

Amnesic shellfish poisoning is caused by domoic acid in shellfish, causing symptoms ranging from gastrointestinal upset to memory loss, coma, and death.

This paper reviews the chemistry, sources, metabolism, toxicology, and mechanism of toxicity of domoic acid, as well as human case reports of amnesic shellfish poisoning (ASP). ASP occurs from consuming shellfish contaminated with domoic acid produced by certain phytoplankton, leading to neuronal degeneration and necrosis in parts of the hippocampus. A 1987 Canadian outbreak linked to contaminated mussels resulted in 150 reported cases, 19 hospitalizations, and 4 deaths, with symptoms spanning gastrointestinal issues to hallucinations, memory loss, and coma.

Jeffery B, Barlow T, Moizer K, et al. Food Chem Toxicol, 2004. PMID 15019178

2004 / Literature review

Dietary sources and tobacco smoke contribute to human exposure to the beta-carbolines norharman and harman.

This review summarizes literature data on levels of norharman and harman in fried meat and fish, meat extracts, alcoholic beverages, coffee brews, edible and medicinal plants, and tobacco smoke. Dietary exposure is estimated up to 4 µg norharman/kg body weight/day and 1 µg harman/kg body weight/day, while endogenous formation is estimated at 50-100 ng/kg body weight/day for norharman and about 20 ng/kg body weight/day for harman. Biomarker studies show elevated plasma levels in certain diseased patients, alcoholics, and following smoking or consumption of beta-carboline-containing food.

Pfau W, Skog K J Chromatogr B Analyt Technol Biomed Life Sci, 2004. PMID 15036003

2004 / Review

Free fatty acids decrease glucose-6-phosphate in human skeletal muscle, indicating direct inhibition of glucose transport or phosphorylation.

This review examines mechanisms by which free fatty acids inhibit glucose utilization in human skeletal muscle. While rat studies showed glucose-6-phosphate accumulation from substrate competition, human muscle studies demonstrate that free fatty acids decrease glucose-6-phosphate, pointing to direct inhibition of glucose transport/phosphorylation. This mechanism may redirect glucose from muscle to the brain during fasting and explain insulin resistance linked to obesity and high-lipid diets.

Roden M News Physiol Sci, 2004. PMID 15143200

2004 / Narrative review

Vitamin B12 deficiency occurs in >20% of elderly people, most frequently caused by food-cobalamin malabsorption syndrome (>60% of cases).

This review examines the epidemiology, causes, diagnosis, and management of vitamin B12 (cobalamin) deficiency in elderly individuals. Cobalamin deficiency occurs frequently (> 20%) in elderly people but is often unrecognized due to subtle manifestations that are potentially serious neuropsychiatrically and hematologically. The most frequent causes are food-cobalamin malabsorption syndrome (> 60% of all cases) and pernicious anemia (15%-20% of all cases), along with insufficient dietary intake and malabsorption.

Andrès E, Loukili NH, Noel E, et al. CMAJ, 2004. PMID 15289425

2004 / Narrative review

Epidemiological studies indicate that smoking is linked to a lower incidence of Parkinson's disease.

Epidemiological research demonstrates that smoking is associated with a reduced incidence of Parkinson's disease. Smoke contains multiple chemicals that may contribute to this observation, with nicotine specifically considered due to its stimulation of brain dopaminergic systems, neuroprotective effects, and provision of symptomatic benefit in the disease. Exploring nicotine's putative factors and signaling pathways is highlighted as crucial for developing intervention strategies to slow or stop Parkinson's disease progression.

Shows an association, not proof of cause and effect.

Quik M Trends Neurosci, 2004. PMID 15331239

2004 / Critical review of 57 experimental and 9 survey studies

A critical review empirically validated caffeine withdrawal symptoms, finding a 50% incidence of headache and symptom onset 12-24 hours after abstinence.

Researchers conducted a critical review of 57 experimental and 9 survey studies to validate human caffeine withdrawal symptoms and syndrome characteristics. Ten symptom categories met validity criteria: headache, fatigue, decreased energy/activeness, decreased alertness, drowsiness, decreased contentedness, depressed mood, difficulty concentrating, irritability, and foggy/not clearheaded. In experimental studies, the incidence of headache was 50% and clinically significant distress or functional impairment was 13%. Onset typically occurred 12-24 hours after abstinence, peaked at 20-51 hours, and lasted 2-9 days, with symptoms observed from doses as low as 100 mg/day.

Juliano LM, Griffiths RR Psychopharmacology (Berl), 2004. PMID 15448977

2003 / Narrative review / proposed disease model

A review proposes that food-derived opioid peptides (exorphins) and serotonin uptake modulators in urine may mediate autism pathophysiology.

This review presents an autism model based on the discovery of food protein-derived opioid peptides (exorphins) in the urine of autistic patients. The authors suggest that exorphins and serotonin uptake-stimulating factors may explain many signs, symptoms, and behavioural effects seen in autistic disorders. They propose that these compounds are key mediators of autism development, potentially caused by genetically based peptidase deficiencies triggered by dietary overload of exorphin precursors or increased gut uptake.

Reichelt KL, Knivsberg AM Nutr Neurosci, 2003. PMID 12608733

2003 / Review

Adding DHA and ARA to infant formula matches breastfed blood levels, but functional benefits for vision and neural development remain controversial.

Arachidonic acid (ARA) and docosahexaenoic acid (DHA) are long-chain polyunsaturated fatty acids (LCPUFA) concentrated in brain and retinal membranes. Infants fed infant formula (IF) containing LCPUFA achieve red cell and plasma ARA and DHA levels comparable to breastfed infants, unlike those fed IF with only precursor fatty acids. However, functional benefits regarding visual or neural development from LCPUFA-supplemented formula remain controversial, and risks of excessive or imbalanced intake exist as other infant foods are fortified.

Koo WW J Am Coll Nutr, 2003. PMID 12672705

2003 / Narrative review

Whole grains show protective links against heart attack, diabetes, and stroke, while human evidence for cancer protection remains inconclusive.

This review examines the health effects of rye, plant lignans, and the dietary fibre complex. Human evidence does not currently warrant the conclusion that rye, whole grains, or phyto-oestrogens protect against cancer, though some studies suggest benefits for upper digestive tract cancers. Conversely, prospective epidemiological studies demonstrate protective effects of wholegrain cereals against myocardial infarction, diabetes, and ischaemic stroke, likely tied to factors within the dietary fibre complex.

Shows an association, not proof of cause and effect.

Hallmans G, Zhang JX, Lundin E, et al. Proc Nutr Soc, 2003. PMID 12749346

2003 / Narrative review

A review discusses the potential mechanism linking milk-derived beta-casomorphin to apnea in sudden infant death syndrome.

This review summarizes findings on the possible relationship between beta-casomorphin (beta-CM) and apnea in sudden infant death syndrome (SIDS). Beta-CM is an exogenous bioactive peptide derived from casein in milk with opioid activity. The authors discuss how circulating beta-CM might cross the immature blood-brain barrier and inhibit the brainstem respiratory center, potentially leading to apnea.

Shows an association, not proof of cause and effect.

Sun Z, Zhang Z, Wang X, et al. Peptides, 2003. PMID 12948848

2003 / Narrative review

Over-the-counter antacids are the main source of human aluminium exposure, while European patient leaflets vary widely in toxicity warnings.

This review notes that aluminium toxicity, initially linked to bone and brain disorders in chronic renal failure, can occur via dialysis fluids, parenteral nutrition, and oral medications like antacids and phosphate binders. Over-the-counter antacids represent the most important quantitative source of human aluminium exposure, with potential neurotoxic as well as embryonic and fetal toxic effects. However, European patient information leaflets for over-the-counter antacids differ substantially in their warnings, including those regarding increased absorption from concomitant citrate-containing beverages and use during pregnancy.

Reinke CM, Breitkreutz J, Leuenberger H Drug Saf, 2003. PMID 14583063

2003 / Narrative review

Ketones serve as alternative brain fuel and hyperketogenic diets hold therapeutic potential for several neurological and neurodegenerative disorders.

This review summarizes the history and metabolic understanding of ketones. In the 1920s, a hyperketogenic diet proved effective for drug-resistant pediatric epilepsy, and in 1967 ketones were shown to replace glucose as the brain's major fuel during prolonged fasting. Diet-induced hyperketonemia was later found therapeutic for rare genetic disorders affecting neuronal glucose use. Given evidence of mitochondrial dysfunction and reduced bioenergetic efficiency in Parkinson's and Alzheimer's disease brains, the authors note that hyperketogenic diets should be evaluated for potential benefits in these conditions.

VanItallie TB, Nufert TH Nutr Rev, 2003. PMID 14604265

2003 / Review

Anecdotal reports suggest products containing quinine may produce neurological complications, particularly in older women.

Quinine is widely available in beverages including tonic water and bitter lemon, despite a U.S. FDA ban for nocturnal leg cramps due to lack of safety and efficacy. Numerous anecdotal reports suggest quinine-containing products may produce neurological complications, including confusion, altered mental status, seizures, and coma, particularly in older women. The abstract states that psychologists need to inquire about the consumption of quinine-containing beverages as part of an evaluation process.

Shows an association, not proof of cause and effect.

Brasić JR Psychol Rep, 2003. PMID 14765563

2002 / Narrative review

Common toxicologic exposures such as lead, mercury, and PCBs impair child neurodevelopment at background population levels.

This review introduces literature examining the impact of chemical exposures on the developing brain. Research demonstrates that substances such as lead, mercury, and PCBs impair development at exposure levels currently experienced by significant portions of the general population, contributing to deficits in attention, memory, learning, social behavior, and IQ. Among the 3,000 chemicals produced in the highest volumes, only 12 have been adequately tested for neurodevelopmental effects.

Stein J, Schettler T, Wallinga D, et al. J Dev Behav Pediatr, 2002. PMID 11875286